Clinical Trial

An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the status of AE and improvement effect of K-CAB Tab/K-CAB ODT(Tegoprazan) 50mg in patients with GERD.
Trial Details
NCT Number NCT07678177
Lead Sponsor HK inno.N Corporation
Conditions GERD (Gastroesophageal Reflux Disease)
Enrollment 5,384 participants
Start Date 2023-03-07
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-01